SEC 13F Intelligence

Mass General Brigham, Inc / FULC

Mass General Brigham, Inc’s Fulcrum Therapeutics Inc Position

Does Mass General Brigham, Inc own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 205.4K shares worth $733,121 in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$733,121
Q3 2024
Shares
205.4K
% of Portfolio
+1.68%
Quarters Held
4
position exited

Position History FULC

Reported value by quarter
Q3 ’21: $447,000Q3 ’21Q1 ’24: $2MQ1 ’24Q2 ’24: $1MQ2 ’24Q3 ’24: $733,121Q3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024205.4K$733,121+1.68%
Q2 2024205.4K$1M+6.20%
Q1 2024205.4K$2M+3.39%
Q3 202115.9K$447,000+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mass General Brigham, Inc’s full portfolio or all institutional holders of FULC.